Non-Interventional Study of Ranicabtagene Autoleucel Injection for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Establishing real-world data of patients with relapsed/refractory B-cell non-Hodgkin lymphoma (r/r B-NHL) treated with Ranicabtagene Autoleucel Injection to evaluate its efficacy and safety.
Epistemonikos ID: 74e07d61d74ef14f106ba376823823417154b710
First added on: Oct 23, 2026